Greg Twinney, CEO
Michel Laberge, Chief Science Officer and Founder
Michael Delage, CTO
Date | Amount | Funder(s) | Description |
---|---|---|---|
August 09, 2023 | $25,000,000 | Series F | |
December 01, 2021 | $130,000,000 | ||
January 14, 2021 | |||
December 16, 2019 | $65,000,000 | Series E | |
October 26, 2018 | $37,500,000 | Federal investment | |
August 11, 2015 | $2,096,794 | ||
May 19, 2015 | $19,400,000 | Series D | |
May 19, 2015 | $1,796,794 | ||
February 26, 2014 | $2,081,772 | ||
December 21, 2012 | $1,570,740 | ||
May 05, 2011 | $1,641,139 | ||
May 04, 2011 | $19,500,000 | Series B | |
June 01, 2010 | $1,000,000 | ||
July 24, 2009 | $9,000,000 |
Date | Amount | Funder(s) | Description |
---|---|---|---|
June 15, 2022 | INFUSE: Beyond Neoclassical Closures for MHD Simulation of General Fusion Devices via Kinetic Monte Carlo Calculations | ||
June 15, 2022 | INFUSE: Tritium Fuel Cycle Modelling and Optimization to Enable Fusion Pilot Plant Development | ||
August 14, 2020 | INFUSE: Advanced stability analysis for magnetized target fusion | ||
March 14, 2016 | $8,700,000 | Grant |